Predictive Value of Early Warning Scores for Procalcitonin and CRP in Hospitalized Community-Acquired Pneumonia Patients

Authors

DOI:

https://doi.org/10.30994/jnp.v8i2.610

Keywords:

CPR, EWS, procalcitonin

Abstract

Background: Pneumonia is a lower respiratory tract infection that causes the most deaths worldwide. There is a lack of knowledge about the predictive value of Early Warning Score (EWS) for procalcitonin, CRP, Mortality in Community Acquired Pneumonia (CAP).

Purpose: The aim of this study was to see how accurate the EWS is at predicting procalcitonin, CRP and the mortality in Community Acquired Pneumonia patients who are hospitalized. All adult patients who were hospitalized for confirmed CAP between March and June 2023 were retrospectively included.

Methods: A Total of 61 confirmed CAP patients treated in Internal Medicine High Care Unit were included in the present study.

Results: The results showed that EWS≥8 was equivalent to procalcitonin in the septic shock category with (OR: 4.667), while EWS≥7 was equal to high risk CRP with (OR: 5.727), and the risk of mortality (83.3%).

Conclusion: Based on the data analysis test, it concluded that EWS could used as a measuring tool to predict procalcitonin and CRP values, as well as mortality risk.

Downloads

Download data is not yet available.

References

Alam, N., Hobbelink, E. L., van Tienhoven, A. J., van de Ven, P. M., Jansma, E. P., & Nanayakkara, P. W. B. (2014). The impact of the use of the Early Warning Score (EWS) on patient outcomes: A systematic review. Resuscitation, 85(5), 587–594. https://doi.org/10.1016/j.resuscitation.2014.01.013.

Almirall, J., Bolíbar, I., Toran, P., Pera, G., Boquet, X., Balanzó, X., & Sauca, G. (2004). Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia. Chest, 125(4), 1335–1342. https://doi.org/10.1378/chest.125.4.1335.

Bader, M. S., Yi, Y., Abouchehade, K., Haroon, B., Bishop, L. D., & Hawboldt, J. (2016). Community-Acquired Pneumonia in Patients With Diabetes Mellitus: Predictors of Complications and Length of Hospital Stay. The American Journal of the Medical Sciences, 352(1), 30–35. https://doi.org/https://doi.org/10.1016/j.amjms.2016.02.032.

Bafadhel, M., Clark, T. W., Reid, C., Medina, M. J., Batham, S., Barer, M. R., Nicholson, K. G., & Brightling, C. E. (2011). Procalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD. Chest, 139(6), 1410–1418. https://doi.org/10.1378/chest.10-1747.

Barak-Corren, Y., Horovits, Y., Erlichman, M., & Picard, E. (2021). The prognostic value of C-reactive protein for children with pneumonia. Acta Paediatrica, International Journal of Paediatrics, 110(3), 970–976. https://doi.org/10.1111/apa.15580.

Corrao, S., Argano, C., Natoli, G., Nobili, A., Corazza, G. R., Mannucci, P. M., & Perticone, F. (2018). Disability, and not diabetes, is a strong predictor of mortality in oldest old patients hospitalized with pneumonia. European Journal of Internal Medicine, 54, 53–59. https://doi.org/https://doi.org/10.1016/j.ejim.2018.04.012.

Fang, A. H. Sen, Lim, W. T., & Balakrishnan, T. (2020). Early warning score validation methodologies and performance metrics: a systematic review. BMC Medical Informatics and Decision Making, 20(1), 1–7. https://doi.org/10.1186/s12911-020-01144-8.

Fine, M. J., Auble, T. E., Yealy, D. M., Hanusa, B. H., Weissfeld, L. A., Singer, D. E., Coley, C. M., Marrie, T. J., & Kapoor, W. N. (1997). A prediction rule to identify low-risk patients with community-acquired pneumonia. The New England Journal of Medicine, 336(4), 243–250. https://doi.org/10.1056/NEJM199701233360402.

Hodgson, L. E., Congleton, J., Venn, R., Forni, L. G., & Roderick, P. (2018). NEWS2 - too litte evidence to implement? Clinical Medicine, 18(5), 371–373.

Huffstetler, A. N., Ramirez, S. I., Dalrymple, S. N., & Mendez Miller, M. H. (2021). Women’s Health and Gender-Specific Considerations. Primary Care: Clinics in Office Practice, 48(1), 117–129. https://doi.org/https://doi.org/10.1016/j.pop.2020.09.008.

Irawan, R., Reviono, & Harsini. (2019a). Respirologi Indonesia. Journal of The Indonesian Society of Respirology, Vol. 39(1), 44–53. https://jurnalrespirologi.org/index.php/jri/article/viewFile/40/25%0Ahttps://jurnalrespirologi.org/index.php/jri/article/download/40/25#:~:text=Pneumonia adalah peradangan paru oleh,gelisah dan nafsu makan berkurang).

Irawan, R., Reviono, & Harsini. (2019b). Respirologi Indonesia. Journal of The Indonesian Society of Respirology, Vol. 39(1), 44–53.

Joffe, E., Justo, D., Mashav, N., Swartzon, M., Gur, H., Berliner, S., & Paran, Y. (2009). C-reactive protein to distinguish pneumonia from acute decompensated heart failure. Clinical Biochemistry, 42(16–17), 1628–1634. https://doi.org/10.1016/j.clinbiochem.2009.08.007.

Jones, M. (2012). NEWSDIG: The national early warning score development and implementation group. Clinical Medicine, Journal of the Royal College of Physicians of London, 12(6), 501–503. https://doi.org/10.7861/clinmedicine.12-6-501.

Julián-Jiménez, A., González del Castillo, J., & Candel, F. J. (2017). Usefulness and prognostic value of biomarkers in patients with community-acquired pneumonia in the emergency department. Medicina Clínica (English Edition), 148(11), 501–510. https://doi.org/10.1016/j.medcle.2017.04.033.

Lubart, E., Boguslavsky, T., Goltsman, G., Muhtaseb, S., & Matveychuk, A. (2023). The incidence of acute renal failure and high mortality rate in elderly patients hospitalized with community acquired pneumonia. Experimental Gerontology, 179, 112242. https://doi.org/https://doi.org/10.1016/j.exger.2023.112242.

MacIntyre, E. J., Majumdar, S. R., Gamble, J.-M., Minhas-Sandhu, J. K., Marrie, T. J., & Eurich, D. T. (2012). Stress Hyperglycemia and Newly Diagnosed Diabetes in 2124 Patients Hospitalized with Pneumonia. The American Journal of Medicine, 125(10), 1036.e17-1036.e23. https://doi.org/https://doi.org/10.1016/j.amjmed.2012.01.026.

Martin-Loeches, I., & Torres, A. (2021). New guidelines for severe community-acquired pneumonia. Current Opinion in Pulmonary Medicine, 27(3), 210–215. https://doi.org/10.1097/MCP.0000000000000760.

Minnaard, M. C., De Groot, J. A. H., Hopstaken, R. M., Schierenberg, A., De Wit, N. J., Reitsma, J. B., Broekhuizen, B. D. L., Van Vugt, S. F., Neven, A. K., Graffelman, A. W., Melbye, H., Rainer, T. H., Steurer, J., Holm, A., Gonzales, R., Dinant, G. J., Van De Pol, A. C., & Verheij, T. J. M. (2017). The added value of C-reactive protein measurement in diagnosing pneumonia in primary care: A meta-analysis of individual patient data. Cmaj, 189(2), E56–E63. https://doi.org/10.1503/cmaj.151163.

Park, C. M., Kim, W., Lee, E. S., Rhim, H. C., Cho, K. H., Kim, J. H., & Kim, D. H. (2022). Comparison of Frailty Index to Pneumonia Severity Measures in Older Patients With Pneumonia. Journal of the American Medical Directors Association, 23(1), 165–169. https://doi.org/10.1016/j.jamda.2021.08.044.

Purwitasari, M., Burhan, E., & Z. Soepandi, P. (2017). Peranan Prokalsitonin Pada Pneumonia Komunitas. The Indonesian Journal of Infectious Diseases, 2(2), 33. https://doi.org/10.32667/ijid.v2i2.25.

Ranzani, O. T., Taniguchi, L. U., & Torres, A. (2018). Severity scoring systems for pneumonia: Current understanding and next steps. Current Opinion in Pulmonary Medicine, 24(3), 227–236. https://doi.org/10.1097/MCP.0000000000000468.

Riskesdes kemenkes RI, 2018. (2018). Laporan_Nasional_RKD2018_FINAL.pdf. In Badan Penelitian dan Pengembangan Kesehatan (p. 674).

Sbiti-Rohr, D., Kutz, A., Christ-Crain, M., Thomann, R., Zimmerli, W., Hoess, C., Henzen, C., Mueller, B., & Schuetz, P. (2016). The National Early Warning Score (NEWS) for outcome prediction in emergency department patients with community-acquired pneumonia: results from a 6-year prospective cohort study. BMJ Open, 6(9), e011021. https://doi.org/10.1136/bmjopen-2015-011021.

Schuetz, P., Amin, D. N., & Greenwald, J. L. (2012). Role of procalcitonin in managing adult patients with respiratory tract infections. Chest, 141(4), 1063–1073. https://doi.org/10.1378/chest.11-2430.

Sungurlu, S., & Balk, R. A. (2018). The Role of Biomarkers in the Diagnosis and Management of Pneumonia. Clinics in Chest Medicine, 39(4), 691–701. https://doi.org/https://doi.org/10.1016/j.ccm.2018.07.004.

Tamura, M., Watanabe, M., Nakajima, A., Kurai, D., Ishii, H., Takata, S., Nakamoto, K., Sohara, E., Honda, K., Nakamura, M., Inui, T., Wada, H., Takizawa, H., & Goto, H. (2014). Serial quantification of procalcitonin (PCT) predicts clinical outcome and prognosis in patients with community-acquired pneumonia (CAP). Journal of Infection and Chemotherapy, 20(2), 97–103. https://doi.org/10.1016/j.jiac.2013.09.005.

Tripon, R.-E., Cristea, V., & Lupse, M.-S. (2021). The role of qSOFA score and biomarkers in assessing severity of community-acquired pneumonia in adults. Revista Romana de Medicina de Laborator, 29(1), 65–75. https://doi.org/10.2478/rrlm-2020-0038.

Zhou, H. (2020). Outcome prediction value of National Early Warning Score in septic patients with community-acquired pneumonia in emergency department: A single-center retrospective cohort study. World Journal of Emergency Medicine, 11(4), 206. https://doi.org/10.5847/wjem.j.1920-8642.2020.04.002.

Downloads

Published

2025-01-30

How to Cite

Pratiwi Yuliansari, Zauhani Kusnul, Agit Pratama Putra, & Yuly Peristiowati. (2025). Predictive Value of Early Warning Scores for Procalcitonin and CRP in Hospitalized Community-Acquired Pneumonia Patients. Journal Of Nursing Practice, 8(2), 427–436. https://doi.org/10.30994/jnp.v8i2.610

Issue

Section

Articles